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ABSTRACT
Summary measures of population health—health
expectancies in particular—have become a standard for
quantifying and monitoring population health. To date,
cross-national comparability of health expectancies is
limited, except within the European Union (EU). To
advance international comparability, the European Joint
Action on Healthy Life Years ( JA: EHLEIS) set up an
international working group. The working group
discussed the conceptual basis of summary measures of
population health and made suggestions for the
development of comparable health expectancies to be
used across the EU and Organisation for Economic
Co-operation and Development (OECD) members. In this
paper, which summarises the main results, we argue
that harmonised health data needed for health
expectancy calculation can best be obtained from
‘global’ survey measures, which provide a snapshot of
the health situation using 1 or a few survey questions.
We claim that 2 global measures of health should be
pursued for their high policy relevance: a global measure
of participation restriction and a global measure of
functional limitation. We ﬁnally provide a blueprint for
the future development and implementation of the 2
global measures. The blueprint sets the basis for
subsequent international collaboration, having as a core
group Member States of the EU, the USA and Japan.
Other countries, in particular OECD members, are invited
to join the initiative.
BACKGROUND
Summary measures of population health—health
expectancies in particular—have become a stand-
ard for quantifying and monitoring population
health.1 2 Health expectancies indicate the number
of remaining years that a person is expected to live
in a health state such as in good (bad) perceived
health, with(out) disability or with(out) chronic dis-
eases. The indicators were developed to address
whether or not longer life is being accompanied by
an increase in the time lived in good or in bad
health, adding a dimension of quality to the quan-
tity of life lived.3 Health expectancies provide
useful information for health, disability, ageing and
social policies. They are also valuable to compare
countries with each other not only to create rank-
ings, but to learn from countries’ experiences. Such
comparisons are effective providing that the data
used—especially the health data—are equivalent
across countries.
To date, cross-national comparability of health
expectancies is limited, except within the European
Union (EU). Since 2005, three harmonised health
expectancies have been annually monitored in the
EU: life expectancy without activity limitation—
also known as Healthy Life Years—life expectancy
in good self-rated health and life expectancy
without chronic morbidity. Each indicator is based
on one of the three global survey questions
forming the Minimum European Health Module
(MEHM).4 Outside the EU, health expectancies
often target analogous health dimensions but rely
on different measures, as it is the case in the USA.5
It therefore appears that international comparability
could be better achieved based on clear conceptual
speciﬁcation of the health dimensions targeted and
the use of measurement guidelines.6
To advance international comparability, the
European Joint Action on Healthy Life Years ( JA:
EHLEIS, http://www.eurohex.eu) set up a working
group composed of experts from the EU, Japan,
the USA, the Organisation for Economic
Co-operation and Development (OECD) and the
WHO. During three seminars held in Paris between
2012 and 2014, the working group discussed the
conceptual basis of summary measures of popula-
tion health and made suggestions for the develop-
ment of comparable health expectancies to be used
across the EU and OECD members (see online sup-
plementary ﬁle for more details on the working
group seminars and methods).7 8 This paper pre-
sents the main results from the working group: it
sketches a blueprint for the future development
and implementation of two global measures of
population health to be used to calculate compar-
able health expectancies.
USING GLOBAL SURVEY MEASURES TO EASE
HEALTH MONITORING
National agencies are often reluctant to introduce
lengthy survey instruments into their monitoring
systems, invoking space restrictions and unwilling-
ness to break existing time series by the replace-
ment of existing instruments. This priority given to
national interests may well contribute to explaining
why cross-national comparisons of health data are
still limited despite international harmonisation
efforts.
To overcome the difﬁculty, global health mea-
sures have been proposed as a pragmatic solution
for collecting comparable health data. Global
health measures, sometimes called ‘general’ mea-
sures, provide a snapshot of the health situation
using one or a few survey questions.4 9 They are
designed to require little room and time, which
makes their inclusion in various health and non-
health surveys easier and, therefore, facilitates fre-
quent measurement and better monitoring over
time. Recent experience with the MEHM has
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revealed that having a short set of questions was an effective
way of increasing the acceptance of health questions into (non-)
health surveys and censuses. Items from the MEHM were, for
example, included into the Statistics on income and living condi-
tions (EU-SILC), national surveys or censuses (eg, in France) and
are going to be part of the future European Labour Force Survey.
Global health measures are therefore good candidates for the cal-
culation of internationally harmonised health expectancies.
To identify appropriate global heath instruments, we have spe-
ciﬁed four technical constraints that a good candidate should
comply with: it should be concise but simple, usable for general
population surveys and amenable to multimodes of collection
(table 1).10–12
It is worth noting that global health instruments are usually
not designed to capture health comprehensively. Global mea-
sures rather target separate health dimensions (eg, self-rated
health, impairments, chronic conditions, activity limitations),
which allows to calculate dimension-speciﬁc health expectancies
(eg, life expectancy with some, severe or no activity limitation).
In this respect, an approach based on global instruments differs
from other summary measures of population health that
combine multiple health dimensions, such as quality-adjusted life
years (QALY) or health-adjusted life expectancies (HALEs). The
later often use utility weights to combine wider set of items cap-
turing multiple domains of health.13 Our approach also differs
from the Global Burden of Disease (GBD) study which impedes
regular monitoring and cross-country comparability by the amount
of data required for the calculation of disability-adjusted life years
or HALEs. For example, the latest HALEs of the GBD necessitate
to estimate the prevalence of no less than 2337 sequelae of 301
diseases and injuries by age and sex, and for each country.14
In this paper, we argue that global survey instruments are the
most suitable measures for regular and comparable monitoring
of population health across multiple countries. When possible,
however, they should be complemented with more speciﬁc
instruments that can provide a greater depth of understanding
through more detailed questions covering the health domains.4
TWO DIMENSIONS OF HEALTH AS A MEASUREMENT
PRIORITY
There is no one single global measure of health but a range of
measures that may tell (in)consistent stories about the health of
the population as they may cover different dimensions.15
Among the many dimensions of health, disability, mental health
and chronic morbidity receive a high level of consideration
from (public) health researchers and practitioners surveyed by
the JA-EHLEIS (see online supplementary ﬁle). We argue that
disability is the key dimension for which a global measure is
needed in order to obtain internationally comparable health
expectancies. In fact, disability represents the consequence of
injury and disease. As such it encompasses many other dimen-
sions of health giving it an advantage over other more speciﬁc
health dimensions such as chronic conditions or mental health.
Disability, like health, is a complex and multifaceted concept
making comprehensive measurement with a global instrument
difﬁcult.16 17 Of the different components of disability, partici-
pation restriction18 and functional limitation11 19 20 were
selected as the main goals for internationally harmonised global
measures of health (box 1).
In the literature, attention has shifted from the medical model
to the ‘biopsychosocial’ model of disability, which integrates
environmental factors and puts the emphasis on participation—
the ultimate step in the disablement process.21 22 Participation
restriction accounts for: (1) the impact of the prevention, treat-
ment and rehabilitation on impairment and functional limita-
tions; and (2) the impact of actions aiming to increase the
participation of people with functional limitations (accommoda-
tions and enabling environments). As measuring participation
restriction alone does not enable one to differentiate these two
impacts, a measure of functional limitation is also needed. Both
dimensions are highly desirable owing to their policy relevance.
Disability policies from the United Nations and the EU
emphasise the role of participation restriction and the necessity
Table 1 Technical constraints for global health instruments
Constraint Description
Conciseness A global health instrument must be concise and is obtained from one question or a restricted number of questions (eg, branch-and-stem
format, several items combined). Conciseness should be evaluated in terms of survey time required to answer the question(s).
Simplicity of the question(s) A global health instrument has to be easily grasped by respondents. The cognitive burden on the respondent should be as low as
possible. The grammar and concepts used in the language of reference (ie, English) should have equivalents in other target languages.
The simplicity (or complexity) of a question is best assessed qualitatively using cognitive and field tests. It can also be evaluated during
the design phase using the best practice of questionnaire design. Simplicity can be assessed using: the number of clauses, the number of
words per clause, the inclusion of low frequency words (ie, words which are not often used in everyday life language, such as
‘participation’), the presence of vague or imprecise relative terms (eg, ‘seldom’), the presence of vague or ambiguous noun phrases (such
as abstract nouns which have unclear or ambiguous referent), or the syntax.
Usability for general population
surveys
A global health instrument should be relevant to the adult population targeted in surveys, often individuals aged 15 years or older.
Amenability to multi-modes of
collection
A global health instrument should be useable in self-administered surveys and applicable to telephone and face-to-face interviews, with
no intervention from the interviewer. It should be compatible with proxy responses, that is, responses given on behalf of the selected
respondent. The mode and proxy effects should be considered when designing the instrument and assessed during the test phase.
Box 1 Deﬁnitions of participation restriction and
functional limitation
Participation restriction—refers to limitation in the performance
of roles and social involvement in activities such work and
employment, school, leisure, parenting, housework, community,
social and civic life.18 Participation gains its societal perspective
by performance with or for others and is more inﬂuenced by
environmental factors and social norms than other dimensions
of disability.
Functional limitation—designates limitation in physical and
mental actions.11 20 Actions correspond to the category of
‘willful actions’ reﬂecting overall abilities of body and mind to
carry out basic volitional bodily operations at the level of the
organism (whole person): for example, walking, climbing steps,
hearing, seeing, remembering.19
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to have adequate measures for it.23 24 The United Nations
Convention on the Rights of People with Disabilities deﬁnes
persons with disabilities as “those who have long-term physical,
mental, intellectual or sensory impairments which in interaction
with various barriers may hinder their full and effective partici-
pation in society on an equal basis with others”.24
Ageing policies also acknowledge the importance of participa-
tion. Within the EU for instance, active and healthy ageing is seen
as fundamental to the pursuit of smart, sustainable and inclusive
growth and better jobs.25 The EU is accordingly monitoring the
Healthy Life Years indicator, which is based on a global measure
of participation restriction known as the GALI or Global Activity
Limitation Indicator (box 2).4 26 In spite of its name, the GALI is
considered as a measure of participation restriction rather than a
measure of activity limitation because it implicitly refers to the
ability for societal participation in a variety of settings (eg,
employment/school, housework, leisure activities).21
Furthermore, the GALI and Healthy Life Years became the
major health indicators within overall strategic policies of the
EU, including the Lisbon strategy (2000–2010), the Europe
2020 strategy (2010–2020). This further evidences that partici-
pation restriction is highly relevant to various public policies.
Likewise, functional limitation has been shown to be a central
component of health and disability policies. Recent international
measures of functional limitation were developed by the
Washington Group on Disability Statistics and the Budapest
Initiative in order to speciﬁcally inform policies. Instruments
were designed (1) to monitor the United Nations Convention on
the Rights of Persons with Disabilities by identifying a population
at risk for restrictions in ability to fully participate in society due
to speciﬁc functional limitations in key domains; and (2) to
provide internationally comparable health state statistics.27 28
CHALLENGES AHEAD
Agreement on the health dimensions to target for new inter-
nationally comparable health expectancies is a great step
forward. Yet, major challenges are still ahead. They include the
selection or design/adaptation of appropriate global survey mea-
sures, their adequate implementation into surveys, and ensuring
cross-national comparability. We have sketched guidelines for
future work and suggested how the international community
could take our recommendations forward.
Instruments selection or design
In order to ease acceptability of the pursued disability measures,
we have decided to rely as much as possible on existing work
and available instruments. Our suggestion is twofold:
1. To develop a generic instrument of participation restriction
using the European experience with the GALI development
(box 2);
2. To adopt the core items of the Washington Group short set
instrument on disability to form a global measure of func-
tional limitation and ensure the relevance of all its items for
EU and OECD countries (box 3).
Participation restriction
A generally accepted global measure of participation restriction
is currently missing. Whereas the European GALI is conceptu-
ally close to what is envisaged,15 29–33 its lack of simplicity
hampers its acceptability beyond the EU. Based on previous con-
tributions,9 10 12 17 we speciﬁed six conceptual characteristics of
a desirable global measure of participation restriction (table 2):
(1) comprehensive content of participation; (2) measure of par-
ticipation performance with current accommodation; (3) health
relatedness of the cause of participation restriction; (4) norma-
tive comparison in the level of participation; (5) long-term dur-
ation of restriction; (6) measure severity of restriction in the
response scale (at least three levels).
The ideal measure should include all six conceptual character-
istics while respecting the four technical constraints of global
instruments deﬁned in table 1. In practice, a well-balanced
instrument will have to slightly restrict its conceptual breadth in
order to be concise and simple enough. To reach a well-balanced
instrument, we suggest setting an unconditional constraint on
simplicity, while optimising conciseness. Assessment of other
technical constraints—usability for general population surveys
and amenability to multimodes of collection—is less fundamen-
tal and can be carried out at a later stage.
To optimise conciseness, one should evaluate whether each
conceptual characteristic should be explicitly included in the
ﬁnal instrument or left implicit (see possible implementations in
table 2). Comprehensiveness of the measure of participation,
health relatedness and normative comparison form the core of
Box 2 The Global Activity Limitation Indicator (GALI) as
used* in the European Union
For at least the past 6 months, to what extent have you been
limited because of a health problem in activities people usually
do? Would you say you have been…
severely limited
limited but not severely or
not limited at all?
*Statistics on income and living conditions (EU-SILC), European Health Interview
Survey (EHIS).
Box 3 The four core questions of the Washington Group
short set of questions on disability*
The next questions ask about difﬁculties you may have doing
certain activities because of a health problem.
1. Do you have difﬁculty seeing, even if wearing glasses?
A. No—no difﬁculty
B. Yes—some difﬁculty
C. Yes—a lot of difﬁculty
D. Cannot do at all
2. Do you have difﬁculty hearing, even if using a hearing aid?
A. No—no difﬁculty
B. Yes—some difﬁculty
C. Yes—a lot of difﬁculty
D. Cannot do at all
3. Do you have difﬁculty walking or climbing steps?
A. No—no difﬁculty
B. Yes—some difﬁculty
C. Yes—a lot of difﬁculty
D. Cannot do at all
4. Do you have difﬁculty remembering or concentrating?
A. No—no difﬁculty
B. Yes—some difﬁculty
C. Yes—a lot of difﬁculty
D. Cannot do at all
*http://www.cdc.gov/nchs/data/washington_group/WG_Short_Measure_on_Disability.pdf
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the instrument pursued. We therefore expect to ﬁnd explicit ref-
erence to these characteristics in the ﬁnal instrument, unless it
has been proved that they can remain implicit without altering
the conceptual breadth of the instrument.
At the end of the pretesting of different forms of the instru-
ment, we expect several candidates to emerge with variable
levels of conciseness and conceptual accuracy. A decision will
have to be made regarding the balance between conceptual
breadth and conciseness.
Functional limitation
From a conceptual perspective, our pursued global measure of
functional limitation should be comprehensive; measure func-
tioning ‘within, on or near the skin’28; and assess the severity of
the limitations.
The Washington Group on Disability Statistics recently sug-
gested a short set of six items, each capturing a domain of func-
tioning in a basic action or activity. The six domains are vision,
hearing, mobility, communication, cognition/remembering and
self-care.27 Our expert consultation and the experience of the
Washington Group (which includes 133 members from National
Statistical Ofﬁces, 7 international organisation members and 6
members from disabled persons organisations) both indicate
that a generic global measure (ie, a one question instrument) of
functional limitation is not feasible. Yet, as such, the Washington
Group short set neither satisﬁes our criterion of parsimony
(table 1), nor fully matches our deﬁnition of functional limita-
tion (box 1). The proposal of the JA: EHLEIS is therefore to
select four of the six Washington Group domains to form a
global instrument (box 3). We excluded the item on self-care
because it does not satisfy the ‘within the skin’ criterion.
Self-care captures more complex activities (ie, washing all over
or dressing) in which it is difﬁcult to disentangle the impact of
the environment. For parsimony purposes, we also decided not
to keep the item on communication, which generally has a
lower prevalence than the other four domains. Further
Table 2 Conceptual characteristics of a desired global measure of participation restriction and possible implementations
Conceptual characteristic Description Possible implementations
1. Comprehensive measures of
participation restriction
The instrument should cover numerous domains of participation such
as work and employment, school, leisure, parenting, housework,
community, social or civic life. It should account for the varying
content of roles and forms of social involvement depending on birth
cohort, age, gender, culture, period and place.
▸ Reference to multiple domains of societal involvement
▸ Reference to societal involvement in general, for
example, ‘activities’
2. Measure of performance with current
accommodation
The instrument should measure performance as opposed to capacity,
that is, what an individual does in his or her current environment. A
measure of performance accounts for differences in the environment
as a ‘scene-setter’ and informs on the extent to which an individual
is adapted—with current accommodation—to his particular
environment, and vice-versa. Performance encompasses the use of
assistive devices and/or personal assistance as well as the built
environment, attitudes towards persons with disabilities and laws on
the rights of persons with disability.
▸ Question or clause on the use of assistive devices
and/or personal assistance
▸ No reference to accommodation if respondents
understand it that way, without a clause
3. Cause of participation restriction: a
health problem
The instrument aims to capture participation restrictions which have a
health cause, as opposed to a socioeconomic cause, for example. It
should cover all health-related reasons, including physical, mental
and emotional health. Consequences of ageing should also be
included as well as ill health caused by injuries/accidents, congenital
conditions, birth defects, etc. It is irrelevant whether the health
problem is diagnosed by a doctor or not. Knowledge about the
specific health problem causing participation restriction is not sought.
▸ General reference to health
▸ Reference to multiple health dimensions (to guide
respondents’ understanding of ‘health’)
▸ No reference to health problems if the survey context
or preceding questions guide the interpretation of the
question as health-related
4. Normative comparison in the level
participation
Following a normative model of disability, the instrument should
assess respondents’ level of participation against population
standards or norms which are relative to cultural and social
expectations. These norms vary by gender, age, culture or social
status. An explicit reference to the norm enables to obtain a relative
measure of disability (as opposed to an absolute measure) and to
assess if people are well adapted to their environment. Such a
measure can be comparable cross-culturally. In practice, the measure
should include a comparison to peers or to the norm. Internal or
habitual comparisons (eg, your usual activities) are not desirable.
▸ Reference to what other people/peers do
▸ No reference to the norm if testing reveals that a
clause does not enhance normative comparison
5. Presence of long-standing restrictions The instrument should target long-standing restrictions. This allows to
obtain more stable estimations of the prevalence of persons with
disabilities and to exclude acute restrictions. Temporary, recurrent or
seasonal restrictions are disregarded, which may in turn leave out the
consequences of some mental health problems. A duration of at least
6 months is often used to define chronic or long-standing diseases in
surveys. This period is also suggested to measure participation
restriction.
▸ Question or clause on duration
▸ No reference to long-standing restrictions if it can be
shown that the respondent interpret a participation
restriction as long-standing
6. Severity of restrictions: inclusion of
full range in the response with at least
three levels
Knowing the degree of severity (or difficulty) is desirable for reporting
variations in population disability and testing hypotheses about
population trends (eg, dynamic equilibrium hypothesis). A measure of
severity with appropriate response options also makes an indicator
more sensitive to change. Yet, measuring severity brings in additional
cut-off points on the disability scale which may vary between cultures
and population subgroups.
▸ 3 response categories
▸ 4 response categories
▸ 5 response categories
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discussion should however evaluate whether the four core
domains selected (box 3) or other domains—such as pain,
fatigue or affect—should be included in a ﬁnal global instru-
ment. Yet, given that the Washington Group short set is already
widely used, is well accepted and was tested in various coun-
tries, strong arguments would be needed in order to include
alternative domains of functioning in the global instrument.
By capturing four domains of functioning—vision, hearing,
mobility and cognition/remembering—the proposed instrument
(box 3) reaches a reasonable level of comprehensiveness at the
cost of slight loss of conciseness (the other technical constraints
(usability for general population surveys, simplicity and amen-
ability to multimodes of collection) also being respected). The
four items are structurally independent which means that the
level of limitation in one of the four domains does not predeter-
mine the level of limitation in any of the other domains.28 This
property makes the global instrument of functional limitation
compatible with the calculation of other summary measures of
population health which rely on the use of valid preference-
based weights such as HALE or QALY.34
Translation, testing, validation and implementation
The newly created questions will need to be translated, tested
(including cognitive interviews and focus groups involving the
general population) and validated before implementation. Strict
procedures have to be deﬁned using best practice and existing pro-
tocols for translation, testing and validation.28 35 36 A higher level
of comparability is better achieved if an instrument is implemented
in similar ways across countries.30 Ideally, the data collection
process of the two instruments should be identical in all countries
and deviations from recommendations should be documented.
Ensuring international comparability
Cross-national comparability will have to be investigated. Like
all reported data, global items are subject to cultural differences
in reporting. Different reporting styles do not hamper cross-
country comparisons of trends, but they might be more prob-
lematic if one wants to compare or rank countries based on dis-
ability or health expectancy values. Comparability issues may
involve both the understanding of underlying concepts and the
use of the response scales.
Problems related to concepts should be minimised in the case
of functional limitation, as indicated by the Washington Group
rationale for measuring that speciﬁc dimension of disability.27
For participation restriction, the criterion of normative compari-
son has been proposed as a way of bypassing the problem. The
criterion indicates that the global instrument should capture the
extent to which individuals are restricted in their participation
to the usual activities within a given environment. For example,
it might be understood as going to the pub in England versus
being involved in the local community in the USA. The fact that
the meaning of (in)ability to participate varies by countries
forms the basis of cross-country comparability. Such indicators
provide relative as opposed to absolute measures of disability.37
As far as response scales are concerned, it is known that
cut-off values of scales might have different meanings to differ-
ent populations. The comparability of the response should
therefore be carefully tested.
Future international collaboration
The series of seminars initiated by the JA: EHLEIS sets the basis
for subsequent international collaboration, having as a core
group Member States of the EU, the USA and Japan. Since the
end of the JA: EHLEIS, national agencies from these countries
have taken the recommendations forward and are pursuing the
work. The involvement of national agencies (or international
agencies in the case of the EU) is fundamental to the success of
this initiative, as they ultimately decide to include or not to
include survey items in their monitoring systems. The input
from international organisations (such as WHO and OECD)
should not be minimised, however, and the collaborations
initiated by the JA: EHLEIS should be maintained and
strengthened.
At the 2015 meeting of the Network on Health Expectancy
and Disablement Process (REVES), the JA: EHLEIS initiative
was positively received by (public) health researchers and pro-
fessionals from around the globe, including developing coun-
tries. Given that the proposed blueprint is intended for EU and
OECD members, the joining of low-income countries could
bring additional challenges, such as the questioning of the rele-
vance of the dimensions and items selected in a global context.
The 2016 REVES meeting will take further the discussion.
CONCLUSION
Summary measures of population health—and health expectan-
cies in particular—lack harmonisation outside the EU. In this
paper, we put forward the development of two harmonised
health expectancies to be based on two global measures of
health: a global measure of participation restriction and a global
measure of functional limitation.
The global measure of participation restriction, on the one
hand, needs to be developed using the conceptual characteristics
and guidelines sketched in this paper. The global measure of
functional limitation, on the other hand, should use the ques-
tions developed by the Washington Group but needs further dis-
cussion on the number and selected core domains to be
included.
This paper intends to serve as a blueprint for the actual devel-
opment and implementation of the pursued indicators. Further
work is therefore needed. Other countries, especially OECD
members, are invited to join the initiative.
What is already known on this subject
▸ Summary measures of population health—in particular
health expectancies—have become an essential tool for
quantifying and monitoring population health.
▸ Current data do not allow meaningful comparisons at
international level.
What this study adds
▸ We argue that harmonised health data needed for health
expectancy calculation can best be obtained from ‘global’
survey measures, which provide a snapshot of the health
situation using one or a few survey questions.
▸ Two global measures of health are pursued for their high
policy relevance: a global measure of participation restriction
and a global measure of functional limitation.
▸ We provide a blueprint for the future development and
implementation of the two global measures.
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